Parexel’s Peyton Howell Named to 2019 PharmaVOICE 100

EVP and Chief Commercial & Strategy Officer recognized as one of the 100 most
inspiring people in life sciences for healthcare industry leadership and patient focus

 BOSTON and DURHAM, NC, Aug. 1, 2019Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through to Commercialization, today announced Executive Vice President and Chief Commercial & Strategy Officer Peyton Howell has been named to the PharmaVOICE 100 list of the most inspiring people in the life sciences industry. Ms. Howell was recognized for her contributions across the healthcare sector and her passion for finding better solutions to improve the patient experience.

“Peyton is a driving force for Parexel, bringing strong leadership, fresh ideas and a passion for improving patient lives. With her diverse experience she brings a distinct perspective on the needs of stakeholders from across the healthcare landscape and is committed to delivering new, innovative solutions to meet those needs,” said Chief Executive Officer Jamie Macdonald. “During her tenure with our organization Peyton has brought greater focus on the patient to our studies and is constantly working to improve their experience across the drug development journey. We’re thrilled to see her receive this well-deserved recognition from PharmaVOICE as one of the most inspiring people in life sciences.”

Ms. Howell has more than 25 years of experience across many different aspects of the healthcare sector, including working with and advocating on behalf of life sciences companies and patients facing healthcare access issues. The recognition from PharmaVOICE notes her passion for helping solve the most difficult healthcare problems and highlights several significant milestones she helped to achieve since joining Parexel in 2018, including the launch of Parexel Biotech as well as Parexel’s Patient Innovation Center.

Published annually in the July/August issue, the PharmaVOICE 100 honors those who were nominated and selected for inclusion based on substantive accounts describing how they have inspired or motivated their colleagues, peers, and even competitors; their positive impact on patients, their organizations, and the industry at large; their innovative and game-changing strategies and thinking; their mentorship and guidance to the next generation of leaders; as well as their as their willingness to give their time and resources to their communities and philanthropic causes. To read the 2019 PharmaVOICE profiles, visit www.pharmavoice.com.

About Parexel

Parexel is focused on supporting the development of innovative new therapies to improve patient health. We do this through a suite of services that help life science and biopharmaceutical customers across the globe transform scientific discoveries into new treatments for patients. From clinical trials to regulatory and consulting services to commercial and market access, our therapeutic, technical and functional ability is underpinned by a deep conviction in what we do. For more information, visit our website and follow us on LinkedIn, Twitter and Instagram.

Parexel is a registered trademark of Parexel International Corporation. All other trademarks are the property of their respective owners.

# # #

Parexel Contacts:

Media:
Wendy Ryan
Tel.: +1 781-434-5104
Email: Wendy.Ryan@parexel.com

Kathryn McMahon Arrigg, PAN Communications
Tel.: +1 617-502-4300
Email: Parexel@pancomm.com

 

We are always available for a conversation.

*